GERON CORP(NASDAQ:GERN) stock News

GERN Latest News, Press Relases and Analysis

All

Press Releases

19 days ago - By: Geron Corporation

Geron to Participate in the 2025 Wells Fargo Healthcare Conference

a month ago - By: Geron Corporation

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

a month ago - By: Bragar Eagel & Squire

GERON (GERN) ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

a month ago - By: Geron Corporation

Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

a month ago - By: The Motley Fool

Geron (GERN) Q2 Revenue Jumps 5,477%

a month ago - By: Benzinga - Mentions: OEC VTLE DIN INSE ...

Earnings Scheduled For August 6, 2025

4 months ago - By: The Motley Fool

Why Geron Stock Crept Higher Today

a month ago - By: Zacks Investment Research - Mentions: TELA

Geron (GERN) Reports Q2 Loss, Tops Revenue Estimates

a month ago - By: Benzinga - Mentions: MYGN CYRX LNTH ADAP ...

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

a month ago - By: Geron Corporation

Geron Corporation Reports Second Quarter 2025 Financial Results and Recent Business Highlights

a month ago - By: Geron Corporation

Geron Appoints Harout Semerjian as President and Chief Executive Officer

2 months ago - By: Geron Corporation

Geron Plans to Announce Second Quarter 2025 Financial Results on August 6, 2025

2 months ago - By: Geron Corporation

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

3 months ago - By: Geron Corporation

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

4 months ago - By: Geron Corporation

Geron Announces Presentations at ASCO and EHA Underscoring RYTELO® (imetelstat) Efficacy and Safety Across Range of LR-MDS Patients, and Showcasing Momentum of Myelofibrosis Program

4 months ago - By: Geron Corporation

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

4 months ago - By: Bragar Eagel & Squire

GERON ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

4 months ago - By: Yahoo Finance - Mentions: DHI CMG

Why Geron Corporation (GERN) Is The Best Low Priced Biotech Stock to Buy Now

4 months ago - By: Faruqi & Faruqi, LLP

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Geron

4 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Geron Corporation and Certain Officers - GERN

4 months ago - By: The Gross Law Firm

The Gross Law Firm Reminds Geron Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 12, 2025 - GERN

4 months ago - By: Faruqi & Faruqi LLP

Faruqi & Faruqi Reminds Geron Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 12, 2025 - GERN

4 months ago - By: THE ROSEN LAW FIRM, P. A.

GERN Deadline: GERN Investors with Losses in Excess of $100K Have Opportunity to Lead Geron Corporation Securities Fraud Lawsuit

4 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Geron Corporation and Certain Officers – GERN

4 months ago - By: Levi & Korsinsky, LLP

Contact Levi & Korsinsky by May 12, 2025 Deadline to Join Class Action Against Geron Corporation(GERN)

4 months ago - By: The Schall Law Firm

GERN Investors Have Opportunity to Join Geron Corporation Fraud Investigation with the Schall Law Firm

4 months ago - By: Gross Law Firm

The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Geron Corporation(GERN) Shareholders

4 months ago - By: Bragar Eagel & Squire - Mentions: XIFR DMRC FLNC

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Geron, Digimarc, XPLR, and Fluence and Encourages Investors to Contact the Firm

4 months ago - By: Faruqi & Faruqi, LLP

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Geron

4 months ago - By: Zacks Investment Research - Mentions: WVE

Geron (GERN) Reports Q1 Loss, Lags Revenue Estimates

4 months ago - By: Geron Corporation

Geron Corporation Reports First Quarter 2025 Financial Results and Recent Business Highlights

4 months ago - By: DJS Law Group LLP

GERN Securities Lawsuit Filed Against Geron Corporation- Contact the DJS Law Group to Discuss Your Rights

4 months ago - By: Robbins Geller Rudman & Dowd LLP

GERON CORP (GERN) Stock News

GERN Latest News, Press Relases and Analysis

Geron to Participate in the 2025 Wells Fargo Healthcare Conference

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GERON (GERN) ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Geron (GERN) Q2 Revenue Jumps 5,477%

Earnings Scheduled For August 6, 2025

Why Geron Stock Crept Higher Today

Geron (GERN) Reports Q2 Loss, Tops Revenue Estimates

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Geron Corporation Reports Second Quarter 2025 Financial Results and Recent Business Highlights

Geron Appoints Harout Semerjian as President and Chief Executive Officer

Geron Plans to Announce Second Quarter 2025 Financial Results on August 6, 2025

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Announces Presentations at ASCO and EHA Underscoring RYTELO® (imetelstat) Efficacy and Safety Across Range of LR-MDS Patients, and Showcasing Momentum of Myelofibrosis Program

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GERON ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Why Geron Corporation (GERN) Is The Best Low Priced Biotech Stock to Buy Now

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Geron

INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Geron Corporation and Certain Officers - GERN

The Gross Law Firm Reminds Geron Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 12, 2025 - GERN

Faruqi & Faruqi Reminds Geron Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 12, 2025 - GERN

GERN Deadline: GERN Investors with Losses in Excess of $100K Have Opportunity to Lead Geron Corporation Securities Fraud Lawsuit

INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Geron Corporation and Certain Officers – GERN

Contact Levi & Korsinsky by May 12, 2025 Deadline to Join Class Action Against Geron Corporation(GERN)

GERN Investors Have Opportunity to Join Geron Corporation Fraud Investigation with the Schall Law Firm

The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Geron Corporation(GERN) Shareholders

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Geron, Digimarc, XPLR, and Fluence and Encourages Investors to Contact the Firm

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Geron

Geron (GERN) Reports Q1 Loss, Lags Revenue Estimates

Geron Corporation Reports First Quarter 2025 Financial Results and Recent Business Highlights

GERN Securities Lawsuit Filed Against Geron Corporation- Contact the DJS Law Group to Discuss Your Rights

INVESTOR DEADLINE NEXT WEEK: Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GERN